Morgan Stanley (NYSE: MS) has a higher price-to-earnings ratio of 17.06x compared to its average ratio, The 36-month beta value for MS is at 1.37. Analysts have varying views on the stock, with 14 analysts rating it as a “buy,” 3 rating it as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for MS is 1.25B, and currently, shorts hold a 1.28% of that float. The average trading volume for MS on May 06, 2024 was 8.15M shares.
MS) stock’s latest price update
Morgan Stanley (NYSE: MS)’s stock price has plunge by 1.07relation to previous closing price of 92.65. Nevertheless, the company has seen a 0.87% surge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-03 that NFLX, MS and THC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 3, 2023.
MS’s Market Performance
Morgan Stanley (MS) has seen a 0.87% rise in stock performance for the week, with a 1.47% gain in the past month and a 7.30% surge in the past quarter. The volatility ratio for the week is 1.53%, and the volatility levels for the past 30 days are at 2.15% for MS. The simple moving average for the past 20 days is 2.69% for MS’s stock, with a 9.31% simple moving average for the past 200 days.
Analysts’ Opinion of MS
Many brokerage firms have already submitted their reports for MS stocks, with Keefe Bruyette repeating the rating for MS by listing it as a “Mkt Perform.” The predicted price for MS in the upcoming period, according to Keefe Bruyette is $91 based on the research report published on January 17, 2024 of the current year 2024.
JP Morgan, on the other hand, stated in their research note that they expect to see MS reach a price target of $87, previously predicting the price at $94. The rating they have provided for MS stocks is “Neutral” according to the report published on January 17th, 2024.
HSBC Securities gave a rating of “Hold” to MS, setting the target price at $96 in the report published on January 09th of the current year.
MS Trading at 4.06% from the 50-Day Moving Average
After a stumble in the market that brought MS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.02% of loss for the given period.
Volatility was left at 2.15%, however, over the last 30 days, the volatility rate increased by 1.53%, as shares surge +1.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +9.07% upper at present.
During the last 5 trading sessions, MS rose by +0.87%, which changed the moving average for the period of 200-days by +0.52% in comparison to the 20-day moving average, which settled at $91.25. In addition, Morgan Stanley saw 0.42% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MS starting from GORMAN JAMES P, who sale 100,000 shares at the price of $90.21 back on Apr 18 ’24. After this action, GORMAN JAMES P now owns 414,870 shares of Morgan Stanley, valued at $9,020,530 using the latest closing price.
Smith Charles Aubrey III, the Chief Risk Officer of Morgan Stanley, sale 11,200 shares at $90.09 during a trade that took place back on Apr 17 ’24, which means that Smith Charles Aubrey III is holding 126,190 shares at $1,009,019 based on the most recent closing price.
Stock Fundamentals for MS
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.65 for the gross margin
The net margin for Morgan Stanley stands at 0.15. The total capital return value is set at 0.01. Equity return is now at value 9.52, with 0.78 for asset returns.
Currently, EBITDA for the company is 15.93 billion with net debt to EBITDA at -12.5. When we switch over and look at the enterprise to sales, we see a ratio of 0.79. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.40.
Conclusion
In conclusion, Morgan Stanley (MS) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
